Agalot, Baby Boy .

HRN: 28-79-69  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/11/2026
04/17/2026
IV
250mg
Q12H
Neonatal Sepsis (E. Coli)
Pending Pharmacy Acceptance 

 Indication:  Culture-directedEmpiric Then Culture-directed    Type of Infection:  Bloodstream    Compliance to guidelines: